Leadership Team


Robert Huffstodt - President and Chief Executive Officer

Mr. Huffstodt joined PTS Diagnostics as Chief Financial Officer in July 2001, and was named President and Chief Operating Officer in October 2001. In December 2002, he was promoted to President and Chief Executive Officer. Previously, Mr. Huffstodt was Executive Vice President and Chief Operating Officer for Quatro Systems, Inc., a leading electronics manufacturing services provider in the Southwest. Prior to joining Quatro, Mr. Huffstodt was President and Chief Executive Officer for Lukens Medical Corporation (NASDAQ:LUKN), a manufacturer of various medical devices, primarily surgical sutures, lancets, and other disposables. Mr. Huffstodt began his career as a Certified Public Accountant, and worked for the Metropolitan Services Group, a division of Price Waterhouse located in New York City where he focused on smaller businesses. Mr. Huffstodt holds a Bachelor of Arts in Accounting from the University of Notre Dame.​


William Benedict - Vice President and General Manager

Mr. Benedict came to PTS Diagnostics in 2006 as Director of Operations and later served as Vice President, Technology and Compliance. He was promoted to his current position of Vice President and General Manager in 2013. While at PTS Diagnostics, he has implemented automation and lean manufacturing practices and instituted continual auditing to maintain the highest levels of compliance. He oversees executive management of PTS Diagnostics’ operations, including manufacturing, quality, IT, clinical, and regulatory. Mr. Benedict is a member of the American Society of Quality, Parenteral Drug Association (PDA), and the Regulatory Affairs Professional Society. He holds a Bachelor of Arts in Biology from Purdue University and a Master of Business Administration from the University of Indianapolis.


Stephen Riendeau - Chief Commercial Officer

Mr. Riendeau joined the PTS Diagnostics in 2007 after 17 years of industry-wide sales experience with Specialty Laboratories, Inc., Myriad Genetic Laboratories, Orca Medical Systems, and Abbott Laboratories, Inc. His professional experience prior to PTS Diagnostics included the servicing of individual accounts, territory management, field sales management, and executive direction of corporate accounts. He has overall responsibility for PTS Diagnostics’ global sales in all healthcare segments, sales distribution, and  the development and execution of the company’s strategic sales plan. Mr. Riendeau received a Bachelor of Arts in Economics from Florida State University.


Cliffe AllenVice President, U.S. Sales

Mr. Allen joined PTS Diagnostics as Regional Sales Director in October 2015, before being named Vice President, U.S. Sales in July 2016. He has nearly 30 years of experience in diagnostic and consumer healthcare with Glaxo SmithKline, Roche Diagnostics, and Thermo Fisher Scientific. His previous positions primarily focused on leading teams with responsibility for physician, hospital, managed care, and retail partnerships. He is now leading the PTS Diagnostics U.S. sales team in all segments, as well as the development and execution of the company's strategic plan. Mr. Allen holds a Bachelor of Arts in Accounting from Western Kentucky University.


Keith Moskowitz, PhD - Vice President, Technology & Development

Dr. Moskowitz has more than 30 years of leadership experience directing medical device R&D, liaison, strategy, and management. He is credited with more than a dozen FDA and internationally-cleared diagnostics, devices, and controls. Dr. Moskowitz received a Bachelor of Arts in Biochemistry from Rutgers University and a doctorate in Biochemistry from Temple University School of Medicine and is a member of several professional societies. He is also a Master Project Manager, AAPM, and has numerous patent applications, publications, and published abstracts.


John Hurrell, PhD President of Asia Pacific

Dr. Hurrell joined PTS Diagnostics after serving as Senior Executive Vice President of International Business for Seegene Inc., a molecular diagnostics company located in South Korea. Prior to Seegene, he was President and General Manager of two Quest Diagnostics subsidiaries, and was responsible for growing the overall business of each. He also has held senior leadership positions with Boehringer Mannheim (now Roche Diagnostics), Genzyme, TriPath Imaging, and Inproteo. Dr. Hurrell has a doctorate from Melbourne University, Australia, and was a Fulbright Fellow at Massachusetts General Hospital in the Harvard Medical School.


Andy Anderson, MD - Medical Director

Dr. Anderson trained in Internal Medicine and specializes in Endocrinology. He has more than 35 years of clinical and research experience, including Interim CEO at Antigen Express, Inc.; Director and Senior Scientific Advisor of Generex Biotechnology Corporation; CEO and President of Symcopeia Company; Clinical Associate Professor of Medicine at Indiana University School of Medicine; and Senior Medical Director for Diabetes and Cardiometabolic Medicine at Eli Lilly and Company. Fellowships include the American College of Endocrinology and the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians (U.K.). Dr. Anderson has degrees from Louisiana State University School of Medicine, New Orleans, and Centenary College of Louisiana. 


Mark Morgan - Chief Financial Officer

Mr. Morgan came to PTS Diagnostics with more than 25 years of global finance and administration experience in the life sciences and medical device industries. He oversees all finance and accounting functions, as well as human resources. Mr. Morgan brings expertise in providing strategic leadership and significant experience supporting R&D, supply chain, and IT with companies including Pfizer, Bayer and Mylan Pharmaceuticals. He holds a Bachelor of Arts in Accounting from Indiana State University and a Master of Business Administration from Illinois State University. He has been published in financial journals multiple times, has authored a book, and is also on the Board of Directors of the Institute of Management Accountants (IMA).


Paul Dreier, Vice President, PTS Services / Business Development

Mr. Dreier’s tenure at PTS Diagnostics started in 2016 as the Senior Director of PTS Services. His role at PTS Diagnostics focuses on business development of the company’s informatics and non-device product lines. His software and technology experience includes more than 25 years in the life sciences and defense industries. Starting as a chemist, he grew to love software and analytical instrumentation, eventually moving into companies that focus on those products. With  global experience in more than 45 countries, Mr. Dreier’s past positions include VP, General Manager, and various executive and equity-based management positions in product management and development, sales, and marketing.. Mr. Dreier earned a Bachelor of Science from Elmhurst College, and a Master of Business Administration in International Strategies from The Ohio State University.

Lance Bury, General Counsel

Mr. Bury joined PTS Diagnostics after serving as VP of Financial Reporting at ITT Educational Services, Inc. since 2014. At ITT, he held a senior leadership role that included overseeing legal and regulatory compliance. Mr. Bury has held general counsel and in-house legal positions at an investment banking firm, a software development company, and a manufacturing company. He also has been a Project CFO at IBM, and a financial consultant for several Fortune 500 companies and KPMG. His 20-plus years of legal experience includes eight years in private practice. He earned his Juris Doctorate from the University of California, Hastings College of Law and a Bachelor of Arts from Kean University. In addition to being a licensed attorney, Mr. Bury is also a CPA and CFE. 
​